CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Lazar David E. Chief Executive Officer | Other disposition · Convertible Loan | −368,614 | 0 | ||
| 2025-11-24 | Lazar David E. Chief Executive Officer | Grant or award · Series AA Convertible Preferred Stock | +900,000 | 900,000 | ||
| 2025-10-23 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −967 | $0.82 | $793 | 28,906 |
| 2025-10-23 | Iwicki Mark T Director | Sale | −154,894 | $0.81 | $125K | 103,540 |
| 2025-10-22 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −20,806 | $0.83 | $17K | 41,760 |
| 2025-10-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −32,230 | $0.83 | $27K | 29,873 |
| 2025-10-22 | Bazemore Todd Director | Sale | −47,768 | $0.83 | $40K | 35,932 |
| 2025-10-22 | Brazzell Romulus K SEE REMARKS | Sale | −46,748 | $0.83 | $39K | 35,952 |
| 2025-10-01 | BAKER BROS. ADVISORS LP Former 10% owner | Sale | −50,640 | $1.38 | $70K | 46,480 |
| 2025-10-01 | BAKER BROS. ADVISORS LP Former 10% owner | Sale | −462,967 | $1.38 | $641K | 425,006 |
| 2025-09-30 | BAKER BROS. ADVISORS LP Former 10% owner | Sale | −21,376 | $1.60 | $34K | 97,120 |
| 2025-09-30 | BAKER BROS. ADVISORS LP Former 10% owner | Sale | −195,425 | $1.60 | $312K | 887,973 |
| 2025-08-29 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-06-24 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −4,511 | $4.01 | $18K | 62,566 |
| 2025-06-24 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −3,631 | $4.01 | $15K | 62,100 |
| 2025-06-24 | Bazemore Todd SEE REMARKS | Sale | −4,058 | $4.01 | $16K | 83,699 |
| 2025-06-24 | Brazzell Romulus K SEE REMARKS | Sale | −5,251 | $4.01 | $21K | 82,698 |
| 2025-06-24 | Iwicki Mark T Director | Sale | −13,227 | $4.01 | $53K | 258,433 |
| 2025-06-15 | Rosen Howard B Director | Grant or award | +2,450 | 16,240 | ||
| 2025-06-15 | Rosen Howard B Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 |
Page 1 of 12 · 236 trades